Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06877533 |
| Title | A First-in-Human Open-label, Phase I/Ib Dose Escalation and Expansion Cohort Study of EOS006215 As Monotherapy and in Combination with Pembrolizumab or Other Anticancer Treatments in Participants with Advanced Solid Tumors |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | iTeos Belgium SA |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |